🇩🇪 Locametz in Germany

BfArM authorised Locametz on 9 December 2022

Marketing authorisation

BfArM — authorised 9 December 2022

  • Marketing authorisation holder: NOVARTIS EUROPHARM LIMITED
  • Status: approved

Locametz in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Germany

Frequently asked questions

Is Locametz approved in Germany?

Yes. BfArM authorised it on 9 December 2022.

Who is the marketing authorisation holder for Locametz in Germany?

NOVARTIS EUROPHARM LIMITED holds the German marketing authorisation.